Given ROR1′s role in maintaining cancer stemness and metastasis, approaches that effectively neutralize ROR1 activity or its upstream regulators hold significant promise for not only controlling primary tumor growth but also preventing recurrence in pancreatic cancer patients. The gene discussed is ROR1; the disease is familial pancreatic carcinoma.